{
    "id": "dbpedia_7392_0",
    "rank": 78,
    "data": {
        "url": "https://aisymposium.hsdm.harvard.edu/speakers/",
        "read_more_link": "",
        "language": "en",
        "title": "Speakers",
        "top_image": "https://aisymposium.hsdm.harvard.edu/files/2023/02/Symposium-slideshow-1500-×-500-px.png",
        "meta_img": "https://aisymposium.hsdm.harvard.edu/files/2023/02/Symposium-slideshow-1500-×-500-px.png",
        "images": [
            "https://aisymposium.hsdm.harvard.edu/wp-content/themes/harvard-flex/img/harvard-logo.svg",
            "https://aisymposium.hsdm.harvard.edu/files/2023/02/HSDM_LOGO_clearbkg-1.png",
            "https://aisymposium.hsdm.harvard.edu/files/2023/02/Symposium-slideshow-1500-×-500-px.png",
            "https://aisymposium.hsdm.harvard.edu/files/2023/08/Dimitris_Bertsimas.png",
            "https://aisymposium.hsdm.harvard.edu/files/2023/03/Fernanda_Viegas_HBS-1-943x1024.jpg",
            "https://aisymposium.hsdm.harvard.edu/files/2023/06/Lucia_Cevidanes.jpg",
            "https://aisymposium.hsdm.harvard.edu/files/2023/08/Teresa_Dolan.jpg",
            "https://aisymposium.hsdm.harvard.edu/files/2023/06/Francesca_Dominici.jpg",
            "https://aisymposium.hsdm.harvard.edu/files/2023/06/Rena_DSouza.jpg",
            "https://aisymposium.hsdm.harvard.edu/files/2023/10/Elani-1024x887.jpeg",
            "https://aisymposium.hsdm.harvard.edu/files/2023/09/Maxine-Feinberg.jpg",
            "https://aisymposium.hsdm.harvard.edu/files/2023/09/mariya-Filipova.jpg",
            "https://aisymposium.hsdm.harvard.edu/files/2023/07/Adam-Foresman.jpg",
            "https://aisymposium.hsdm.harvard.edu/files/2023/07/Bob_Gentleman.jpg",
            "https://aisymposium.hsdm.harvard.edu/files/2023/06/Kimberly_Harding.jpg",
            "https://aisymposium.hsdm.harvard.edu/files/2023/06/Adam_Heroux.jpg",
            "https://aisymposium.hsdm.harvard.edu/files/2023/08/Daniel-Pihlstrom.jpg",
            "https://aisymposium.hsdm.harvard.edu/files/2023/08/Kaz-Rafia.jpg",
            "https://aisymposium.hsdm.harvard.edu/files/2023/06/Bernardo_Sabatini.jpg",
            "https://aisymposium.hsdm.harvard.edu/files/2023/09/Cindy-Roark.jpg",
            "https://aisymposium.hsdm.harvard.edu/files/2023/07/Philippe_Salah.jpg",
            "https://aisymposium.hsdm.harvard.edu/files/2023/09/mini-suri.jpg",
            "https://aisymposium.hsdm.harvard.edu/files/2023/09/Ophir_Tanz.jpg",
            "https://aisymposium.hsdm.harvard.edu/files/2023/07/Marko_Vujicic.jpg",
            "https://aisymposium.hsdm.harvard.edu/files/2023/10/Zandparsa-Roya.jpg",
            "https://aisymposium.hsdm.harvard.edu/files/2023/06/Marinka_Zitnik.jpg",
            "https://aisymposium.hsdm.harvard.edu/files/2023/10/Yusuke_Amano.jpg",
            "https://aisymposium.hsdm.harvard.edu/files/2023/10/Choi-headshot-sized.jpg",
            "https://aisymposium.hsdm.harvard.edu/files/2023/10/Balaza_Feher.jpg",
            "https://aisymposium.hsdm.harvard.edu/files/2023/10/Rick-Heard.jpg",
            "https://aisymposium.hsdm.harvard.edu/files/2023/10/David_Lustbader.jpg",
            "https://aisymposium.hsdm.harvard.edu/files/2023/10/Maji_Hiroshi.jpg",
            "https://aisymposium.hsdm.harvard.edu/files/2023/10/Anthony-Morlandt.jpg",
            "https://aisymposium.hsdm.harvard.edu/files/2023/10/Renick.jpg",
            "https://aisymposium.hsdm.harvard.edu/files/2023/10/Falk_Schwendicke.jpg",
            "https://aisymposium.hsdm.harvard.edu/files/2023/10/Michael_Scialabba.jpg",
            "https://aisymposium.hsdm.harvard.edu/files/2023/10/Kirrill_Zaydenman.jpg",
            "https://aisymposium.hsdm.harvard.edu/files/2023/10/Zuckerberg.jpg",
            "https://websites.harvard.edu/globalsymposium-ai-dentistry/files/2023/02/HSDM_LOGO_clearbkg-1-300x54.png"
        ],
        "movies": [],
        "keywords": [],
        "meta_keywords": [
            ""
        ],
        "tags": null,
        "authors": [],
        "publish_date": null,
        "summary": "",
        "meta_description": "Keynote Speakers Dimitris BertsimasBoeing Professor of Operations ResearchAssociate Dean of Business AnalyticsMIT Fernanda ViégasGordon McKay Professor of Computer ScienceHarvard University Speakers Include: Lucia H. Soares CevidanesThomas M. and Doris Graber Endowed Professor of Dentistry University of Michigan Teresa A. DolanChief Dental Officer Overjet Francesca DominiciCo-DirectorData Science InitiativeHarvard University Rena D’SouzaDirector National Institute of Dental and...",
        "meta_lang": "en",
        "meta_favicon": "",
        "meta_site_name": "HSDM Global Symposium AI",
        "canonical_link": "https://aisymposium.hsdm.harvard.edu/speakers/",
        "text": "Dimitris Bertsimas is the Boeing Professor of Operations Research and the Associate Dean of Business Analytics at the Sloan School of Management at the Massachusetts Institute of Technology. He is a member of the US National Academy of Engineering, an INFORMS fellow, recipient of the John von Neumann Theory Prize, the Frederick W. Lanchester Prize, the Erlang Prize, finalist of the Franz Edelman Prize four times, and the INFORMS President’s Award, among many other research and teaching awards, supervisor of 91 completed and 26 current doctoral theses, co-author of seven graduate level textbooks, 300+ publications, editor of the INFORMS Journal on Optimization and co-founder of ten analytics companies and two non-profit foundations.\n\nFernanda Viégas is Gordon McKay Professor of Computer Science at Harvard, and Sally Starling Seaver Professor at the Radcliffe Institute for Advanced Study. Fernanda is also a Principal Scientist at Google, where she co-founded the PAIR (People+AI Research) team. Her work in machine learning with long-time collaborator Martin Wattenberg focuses on transparency and interpretability, as part of a broad agenda to improve human/AI interaction. She is well known for her contributions to social and collaborative data visualization, and the systems her teams have created are used daily by millions of people. Viégas and Wattenberg are also known for their visualization-based artwork, which has been exhibited worldwide, and is part of the permanent collection of the Museum of Modern Art in New York. Viégas holds a PhD from the MIT Media Lab.\n\nYusuke Amano is Chief Technology Officer at ASUA Inc. Before joining to ASUA Inc., he was engaged in system development, leading projects and releasing services using many advanced technologies such as AI and blockchain. After that, he became the company’s internal director and head of operations in 2019. In the same year, he started developing Digital Hygienist, a business for dental clinics using a diagnostic message delivery service, as business director. And a clinical study on the effectiveness of this system as a digital medicine was conducted using a practice-based research network, The McGuire Institute (iMc) in 2021. Currently, based on this diagnostic message delivery service, the company is expanding the AI-based communication technology into the healthcare industry.\n\nGuru Banavar, PhD is Chief Technology Officer at Viome, Inc.,a company that uses advanced microbiology & biochemistry to understand your molecular functions, applies AI & ML technologies to create a high-resolution model of your individual biology, and uses concepts from modern medical science to recommend food and supplements personalized for you. Until April 2017, he was a global Vice President at IBM leading Watson AI research, and a member of CEO Ginni Rometty’s top executive team. Guru has built a range of advanced technologies and delivered solutions in multiple industries throughout his career. He has published extensively, and holds more than 25 US patents. Guru is a recognized thought leader who has spoken on the Nobel, Aspen, and Milken stages, and most recently, delivered the 2017 Turing Lecture. His awards include the Leadership in Technology Management Award from PICMET in 2017, and a National Innovation Award from the President of India in 2009. He has served on NY Governor Cuomo’s commission for NY state resiliency, and was an elected member of the IBM Academy of Technology. Guru has published extensively, and holds more than 25 US patents. His work has been featured in major international media including the New York Times, Economist, Wall Street Journal, BBC, and NPR.\n\nShayan Barootchi, DMD is a Member of the Faculty in the Department of Oral Medicine, Infection, and Immunity at Harvard School of Dental Medicine. Prior to this he was Adjunct Clinical Assistant Professor at the University of Michigan, Department of Periodontics and Oral Medicine after completing a post-doctoral research fellowship and Periodontal residency program, leading to a Certificate and Master’s Degree in Periodontology. Barootchi has conducted numerous research projects in the field of periodontal and peri-implant plastic surgery, root coverage procedures and hard and soft tissue regeneration, ranging from human randomized clinical trials, cross-sectional studies, small and large animal models, in-vitro, and other translational research, many of which have been published in well-known peer-reviewed international journals. His work in this field has led to more than 100 peer-reviewed scientific articles and his research and publications have been the recipients of numerous national and international prestigious awards. He also serves as the associate editor for the Journal of Clinical implant Dentistry and related Research, as well as on the editorial board and as an ad-hoc reviewer for many other internally renowned journals in Dentistry and Periodontology, such as the Journal of Periodontology, Journal of Clinical Periodontology, and the International Journal of Periodontics and Restorative Dentistry. His current research focuses on periodontal and peri-implant hard and soft tissue regeneration as well as contemporary methods for the treatment of peri-implantitis.\n\nChia-Yu (Jennifer) Chen, DDS, DMSc is an Instructor in the Department of Oral Medicine, Infection, and Immunity at Harvard School of Dental Medicine. Chen received her dental degree (DDS) from Kaohsiung Medical University in Taiwan and completed her periodontology training and Doctor of Medical Science (DMSc) in oral biology from Harvard School of Dental Medicine. At HSDM, Chen was selected as a Presidential Scholar and, at graduation, was the recipient of both the James H. Shaw Award for excellence in biomedical research and the Joseph L. Henry Award, which recognizes excellence in research and clinical training from Harvard. Chen is a diplomate of the American Board of Periodontology. She maintains a clinical practice limited to periodontology and implantology in the Faculty Group Practice at the Harvard Dental Center. Chen’s clinical and research interests include the use of innovative concepts, technologies and biomaterials to enhance treatment outcomes and patients’ experiences. She is involved in both preclinical and clinical research related to soft/hard tissue regeneration, implant dentistry and digital dentistry.\n\nDavid Lustbader, DMD is Director of Clinical Affairs at 42 North Dental. Lustbader received his Bachelor of Arts, Magna Cum Laude, and his Doctor of Dental Medicine Degree from Boston University receiving many other awards during his dental education. He completed his Residency in Oral and Maxillofacial Surgery at Long Island Jewish Medical Center in New York with an emphasis on Reconstructive, Implant and Pre-Prosthetic Surgery. He served as Clinical Instructor for SUNY at Stony Brook School of Dental Medicine for two years and at Boston University School of Dental Medicine from 1991 to the present. Lustbader came to South Shore Oral Surgery Associates immediately following his hospital training. From the start his commitment to excellence and providing his patients with the highest quality of care is evidenced both by his fine reputation with his patient and professional community and his dedication to this community. Lustbader is actively involved in numerous local and national societies. Subsequently he spends several hundred hours each year as a presenter at national and regional continuing education events and conventions. Lustbader’s main area of clinical interest is dental implant surgery, of which he has performed over 15,000 procedures. Lustbader is also Chief of Oral and Maxillofacial Surgery at Milton Hospital, and is a clinical instructor at Boston Medical Center.\n\nHiroshi Maji, CEO of ASUA Inc., founded the company in 1994. In 1998, the company began selling products aimed at improving the fuel efficiency of automobiles and later converted its business to specialized consulting for logistics companies. He presented a paper at the Society of Automotive Engineers of Japan in 2006 and proposed “Improving Fuel Efficiency and Reducing Accidents through Eco-Driving Activities”. In 2014, he hosted an Eco-Driving Conference at the United Nations Headquarters, and established the Eco-Driving Declaration in 2016, which was extended to about 50 countries. This activity led to initiatives with Toyota Motor Corporation, and ASUA Inc. have been delivering driver diagnostic messages using Toyota Motor Corporation’s connected data, leveraging the know-how we have cultivated in logistics consulting. In 2019, the company started to develop “Digital Hygienist”, a business for dental clinics that utilizes the diagnostic message delivery service. And a clinical study on the effectiveness of this system as a digital medicine was conducted using a practice-based research network, The McGuire Institute (iMc) in 2021. Currently, based on this diagnostic message delivery service, the company is expanding the AI-based communication technology into the healthcare industry.\n\nTakanari Miyamoto, DDS, PhD, CAGS, MSD, MBA, serves as the Special Professor at Creighton University and is the Executive Founder of Perio Health Institute Japan (PHIJ). PHIJ is a graduate-level private dental institution that provides guidance to dental leaders worldwide on knowledge, technologies, and the rapidly evolving field of science. As a periodontal surgeon, Dr. Miyamoto received extensive education and training. He is also the founder of Metro West Orthodontics + Periodontics, where he practices full-time. With over a decade of educational experience, he has lectured at Boston University and Creighton University. He has held positions as Department Chair of Periodontics and Director of the Predoctoral Program at Creighton University. Additionally, he has served as President of the Omaha District Dental Society, President of the Southwest Society of Periodontists, member of the editorial advisory board for the Journal of Periodontology, and member of the editorial board of the Journal of Oral Science. He is currently a member of the Honor Dental Society-Omicron Kappa Upsilon.\n\nAnthony Morlandt, M.D., D.D.S., F.A.C.S. is fellowship-trained in head and neck cancer surgery and microvascular reconstruction and is a board-certified oral and maxillofacial surgeon. His oncology practice focuses on surgical treatment of tumors involving the oral cavity and oropharynx, salivary glands, skin of the head and neck, and skull base. He is director of the section of Oral Oncology at UAB, the largest oral cancer regional referral program in the U.S. Southeast. Morlandt is the Endowed Peter D. Waite Professor with tenure, and Vice Chairman of the Department of Oral and Maxillofacial Surgery at the University of Alabama at Birmingham. In addition, he directs the head and neck oncology and microvascular surgery fellowship program at UAB. Morlandt holds the position of Medical Quality Officer in UAB Medicine and directs several key quality and safety-related initiatives across the institution. Morlandt serves on the Board of Trustees of the American Association of Craniomaxillofacial Surgeons. Locally, he is a board member of United Ability, an Alabama non-profit dedicated to improving the lives of people with disabilities. Morlandt’s current research focuses on the use of prognostic biomarkers in progression of oral dysplasia to cancer. He is U.S. Chief Medical Officer of Proteocyte AI, a Toronto-based company dedicated to ending late-stage oral cancer detection and improving survival through AI-powered predictive analytics. His work has been published in more than 50 scientific articles and book chapters and he has given over 100 invited oral and video presentations. Morlandt is a Scientist in the Cancer Chemoprevention Program in the O’Neal Comprehensive Cancer Center at the University of Alabama. In 2015, Morlandt received the Faculty Educator Development Award of the American Association of Oral and Maxillofacial Surgeons, the first in Alabama to do so. He has been inducted into the American Head and Neck Society and is a Fellow of both the American College of Surgeons and the American Association of Craniomaxillofacial Surgeons.\n\nNathan Palmer, PhD, is Senior Research Scientist in Biomedical Informatics and Director of Data and Analytics Platforms at the Center for Computational Biomedicine at Harvard Medical School. Palmer received a PhD in computer science from the Massachusetts Institute of Technology, studying machine learning, protein folding, and functional genomics. He then held a postdoctoral research position in the lab of Isaac Kohane at Harvard Medical School, during which his research interests expanded to include large-scale genomics, epidemiology, and medical informatics. He then went on to direct the Healthcare Data Science Program in the Department of Biomedical Informatics at Harvard Medical School. In his current role as Director of Data and Analytics Platforms for the Center for Computational Biomedicine (CCB), Palmer is part of a team of leading-edge technologists who evaluate and deploy modern data analytic processing and storage platforms to meet the needs of emergent research programs supported by CCB, with the goal of improving research reproducibility, scale, and efficiency. This team provides access to data resources comprising tens of billions of medical facts from tens of millions of patients to the research community at HMS, and develops both the technical and methodological solutions to perform novel analytics at scale. Palmer continues to work in the area of functional genomics and epidemiology through collaborations with the various Harvard teaching hospitals.\n\nBarrie Renick BSc, DDS, dip.OralPath, dip.Oral Surg., MRCD(C) is a private practitioner and the only Canadian trained in both Oral Pathology and Oral Surgery specialties. Renick practices oral surgery and surgical management of oral pathology cases in the city of Newmarket 25 miles north of Toronto, serving 400,000 people. Renick was the first clinician to use the Straticyte test in practice, which is the first commercially available AI-driven test that provides a cancer risk score to patients with OPMD (oral potentially malignant disorder). Renick is the Canadian Medical Officer for ProteocyteAI and a member of its Board of Directors.\n\nFalk Schwendicke, PhD, MDPH, is Head of the Department of Oral Diagnostics, Digital Health and Health Services Research at Europe’s largest university hospital, the Charité in Berlin, Germany. He also is the founding director of the Berlin Institute of AI and Health Policy and a Visiting Fellow at the University of Otago, New Zealand. Schwendicke currently serves as Associate Editor of the Journal of Dental Research, as President of the German Association for AI in Dentistry, as Topic Driver Dental at the ITU/WHO group AI in Health and as Vice President of the German Society for Oral Epidemiology and Health Services Research. He is also an Advisor to Align Technology. Schwendicke holds a PhD from Charité – Universitätsmedizin Berlin and a Master of Dental Public Health (MDPH) from the University of Manchester. He received numerous awards, among them the IADR Leader Award, IADR Basil Bibby and IADR Lion Award as well as the David Sackett Award for Evidence-Based Medicine.\n\nMichael Scialabba is the Chief Clinical Officer at 42 North Dental, a leading dental support organization (DSO) with more than 100 supported locations from Maine to Michigan. Scialabba oversees the clinical excellence of more than 330 dentists and specialists. Scialabba also serves as a Gubernatorial appointee to the Massachusetts Board of Registration in Dentistry. Since January 2021, he has been Chairman of the Board. He is a member of the Commission of Dental Competency Assessment and is an examiner for the American Board of Dental Examiners. Scialabba also sits on the Curriculum Committee and Government Affairs committee for the Association of Dental Support Organizations (ADSO) Summit. Scialabba practices at Great Hill Dental Partners in Peabody, Massachusetts, where he has cared for his patients for the past 16 years. He also guest lectures for SUNY Stony Brook in the practice management class for third- and fourth-year dental students. Prior to his current roles, Scialabba worked as Chief of Dentistry for Harvard Vanguard in Peabody, Massachusetts, where he spearheaded its endeavors to become the privately-held, dentist-owned Great Hill Dental Partners in 2010. He also worked as a clinical associate at Dental Care Associates in Brighton, Massachusetts, from 2005-2007. Scialabba is an active member of numerous professional organizations, including the ADSO, Crown Council, American Association of Oral Systemic Health, Academy of General Dentistry, American Dental Association, and the Massachusetts Dental Society. He was featured as a Top Dentist by Boston Magazine from 2016 to 2021. He is a recently appointed fellow of the American College of Dentists. Scialabba attended SUNY Stony Brook School of Dental Medicine and completed his training with a two-year residency program at the Veterans Affairs Medical Center in West Palm Beach, Florida. He completed the American Dental Association’s Dental Practice Management Certificate Program through the Mendoza School of Business at the University of Notre Dame. Scialabba received an undergraduate degree in finance from the Carroll School of Management at Boston College. He is an active member of the Boston College CEO Club and also volunteers his time to the Boston College Eagle Docs program, mentoring undergraduate students who seek dentistry as a profession.\n\nAndreas Werdich, PhD is a Software Engineer at the Center for Computational Biomedicine at Harvard Medical School. Werdich is a physicist who received a Diploma in atomic physics from Freiburg University, Germany, and a PhD in physics from Vanderbilt University. His dissertation was focused on studying the molecular mechanisms of cardiac arrhythmias using high-speed fluorescence imaging of single cells in microfluidic devices. Werdich completed postdoctoral fellowships at Massachusetts General Hospital and Case Western Reserve University and in 2015, joined the faculty of Harvard Medical School at Brigham Women’s Hospital. Since then, he has been specializing in data science and computer vision, using deep learning techniques to uncover new attributes of human health and disease in experimental and clinical data. As a member of the Data and Analytics Platforms Team, Werdich enjoys helping his colleagues at Harvard Medical School to bridge the gaps between biology, medicine, engineering and computer science. He continues to work in the areas of cardiac electrophysiology and arrhythmias through collaborations with Harvard teaching hospitals.\n\nKirill Zaydenman is vice president of product strategy and transformation at Delta Dental of Massachusetts. Kirill leads DDMA’s efforts to enable a transition to more accessible, equitable, and value-based oral health care system by collaborating with and driving value to our dentists, members, and clients. Zaydenman has held several dental and medical industry leadership roles. Most recently, as vice president of innovation at CareQuest Innovation Partners, the for-profit affiliate of CareQuest Institute for Oral Health, Zaydenman developed the company’s strategy and operating model to validate and scale transformative solutions to improve overall health through oral health. Previously, Zaydenman also led product development, strategy, and research at DentaQuest, DDMA, and Blue Cross Blue Shield of Massachusetts. He is deeply passionate about making the health care system better, collaborating with diverse stakeholders, and partnering to find new ways to improve health equity, experience, and outcomes. He also enjoys coaching individuals and teams to achieve business results through change management, data-driven insights, and powerful storytelling. Zaydenman received a master’s degree in foreign service from Georgetown University and a bachelor’s degree in history from Boston University.\n\nEdward J. Zuckerberg, D.D.S., F.A.G.D. is a 1978 Graduate of NYU College of Dentistry. He owned his own practices in Brooklyn and Dobbs Ferry, NY from 1979-2013 and has always been an early adopter of technology, introducing his first PC in the office in 1986 and completely fully networking his home-based office with broadband access in 1996. Zuckerberg’s early adoption of technologies including digital radiography, CAD/CAM & creation of a paperless office caught the attention of industry leaders who enlisted him to lecture, write articles, and beta test new technologies. The advanced technology in the home helped launch his son Mark’s, the founder of Facebook, interest in computers. With his wife of 43 years, Karen, a retired psychiatrist, the couple has three daughters: Randi, former marketing director at Facebook and now CEO of Zuckerberg Media; Donna, who received her classics PhD at Princeton and is now an author and editor of the online publication, Eidolon, featuring a modern way to write about the ancient world; and Arielle, who is a partner in a financial firm in San Francisco; as well as 8 grandchildren. Zuckerberg lectures nationally and internationally on the Oral Systemic Connection; serves as a venture partner at Revere Partners, the first independent venture fund for oral health; acts as the chief dental advisor for both Viome and Keystone Bio in addition to treating patients part time in Cupertino, CA. Zuckerberg authored the chapter on social media on the ADA’s recently released “Practical Guide to Internet Marketing.”"
    }
}